VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 175 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $126 | -51.7% | 30,658 | -50.5% | 0.00% | -50.0% |
| Q4 2023 | $261 | -78.7% | 61,922 | -78.2% | 0.00% | -83.3% |
| Q3 2023 | $1,226 | +209.6% | 283,804 | +429.2% | 0.01% | +100.0% |
| Q4 2022 | $396 | -100.0% | 53,627 | -58.7% | 0.01% | -57.1% |
| Q3 2022 | $1,282,000 | +102.5% | 129,785 | +123.4% | 0.01% | +100.0% |
| Q2 2022 | $633,000 | +65.3% | 58,093 | +137.6% | 0.01% | +250.0% |
| Q4 2021 | $383,000 | +1.6% | 24,450 | +39.1% | 0.00% | -33.3% |
| Q2 2021 | $377,000 | -16.8% | 17,571 | -41.9% | 0.00% | -40.0% |
| Q1 2021 | $453,000 | +319.4% | 30,226 | +168.0% | 0.01% | +66.7% |
| Q3 2020 | $108,000 | -66.6% | 11,279 | -60.1% | 0.00% | -70.0% |
| Q2 2020 | $323,000 | +29.7% | 28,282 | +86.4% | 0.01% | -9.1% |
| Q4 2019 | $249,000 | +88.6% | 15,174 | +44.8% | 0.01% | -82.3% |
| Q2 2015 | $132,000 | – | 10,477 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |